Aflibercept 8 mg in Neovascular AMD—A Fast-Drying Anti-VEGF Drug: A Prospective Morpho-Functional Pilot Study

Authors

Institutions

Publication Details

Journal
Ophthalmology and Therapy
Published
2025-12-12
DOI
https://doi.org/10.1007/s40123-025-01296-8
Primary Topic
Angiogenesis and VEGF in Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aflibercept 8 mg in Neovascular AMD—A Fast-Drying Anti-VEGF Drug: A Prospective Morpho-Functional Pilot Study

Gilda Cennamo, Marina Concilio, Ciro Costagliola, Gaetano Corvino et al.
Ophthalmology and Therapy
Angiogenesis and VEGF in Cancer
article

Aflibercept 8 mg in Neovascular AMD—A Fast-Drying Anti-VEGF Drug: A Prospective Morpho-Functional Pilot Study

Gilda Cennamo, Marina Concilio, Ciro Costagliola, Gaetano Corvino, Raffaele Nubi, Michele Rinaldi, Alessia Riccardo
article en

Abstract

No abstract available for this paper.
Ophthalmology and TherapyVol. 15(2)
University of Molise (IT), Federico II University Hospital (IT)
Openalex Percentile: Top 64%
Angiogenesis and VEGF in Cancer
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.